Rapport Therapeutics Inc. Clinical Trial Pipeline: 4 Active Trials, 2 Changes This Month

4

Active Trials

3

Recruiting

2

Phase 3

2

Disease Areas

2

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-08-11	NCT07046494 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I…	Enrollment closed, study ongoing
2026-08-11	NCT07046494 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I…	date change Completion moved earlier: 2026-11 -> 2026-10

Active Trials by Phase

Phase 3

2

Phase 2

2

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT07594119	Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal…	Focal Seizure	Recruiting
NCT07563881	Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal…	Focal Seizure	Recruiting
Phase 2
NCT07219407	A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset…	Focal Epilepsy	Recruiting
NCT07046494	Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I…	Bipolar 1 Disorder	Active, Not Recruiting

Disease Areas

Get alerts when Rapport Therapeutics Inc.'s trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.